Table 1.
Patient | Location | Stage | Histology | Treatment With Prescription Dose (Gy/Fractions) | CTVHigh Volume (cc) |
---|---|---|---|---|---|
1 | Hard palate | T4bN0 | ACC* | ChemoRT (70/35) | 242 |
2 | Nasopharynx | T1N0 | SCC* | RT (70/33) | 37 |
3 | Base of Tongue | T2N2b | SCC | Surgery+ChemoRT (70/35) | 35 |
4 | Left buccal mucosa | T1N1 | SCC | Surgery+ChemoRT (60/30) | 243 |
5 | Oral Tongue | T1N1 | SCC | Surgery+RT (60/30) | 47 |
6 | Oral Tongue | T2N2b | SCC | Surgery+ChemoRT (70/35) | 41 |
7 | Base of tongue | T2/T3N2b | SCC | ChemoRT (70/35) | 265 |
8 | Nasopharynx | T4N2 | SCC | ChemoRT (70/33) | 79 |
9 | Supraglottis | T2N2c | SCC | RT (66/33) | 113 |
10 | Left Mandible | T2N0 | SCC | Surgery+RT (60/30) | 72 |
Abbreviations:
ACC: adenocarcinoma; SCC: squamous cell carcinoma; ChemoRT: chemoradiotherapy; RT: radiation therapy